Search results for "Expert group"

showing 8 items of 8 documents

Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and me…

2017

PubMed: 28779882

AFRICAPopulation ageingmedicine.medical_specialtyVisual acuity[SDV]Life Sciences [q-bio]PopulationVisual impairmentVision DisordersVisual AcuityEYEBlindnessGlobal Health03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-being[SDV.IDA]Life Sciences [q-bio]/Food engineeringPrevalenceJournal ArticleGlobal healthHumansMedicineVISUAL IMPAIRMENT[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process Engineering030212 general & internal medicineeducationPublic Environmental & Occupational Healtheducation.field_of_studyScience & Technologybusiness.industryMORTALITYPublic healthlcsh:Public aspects of medicineMedicine (all)COSTlcsh:RA1-1270General MedicinePresbyopiamedicine.diseaseVision Loss Expert Group3. Good healthMeta-analysis030221 ophthalmology & optometry/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingHEALTHmedicine.symptombusinessLife Sciences & BiomedicineDemography
researchProduct

Trends in Prevalence of Blindness and Distance and Near Vision Impairment Over 30 Years and Contribution to the Global Burden of Disease in 2020

2020

Background: The Vision Loss Expert Group and Global Burden of Disease Study have extensively updated estimates of global vision loss burden in 2020, temporal changeover 3 decades and forecasts for 2050. Methods: A systematic review and meta-analysis was conducted of population-based datasets relevant to vision impairment (VI) from January 1980 to October 2018. Hierarchical models were fitted to estimate 2020 prevalence (with 95% uncertainty intervals, UI) of (1) mild VI (presenting visual acuity [PVA] 6/12). Findings: In 2020, an estimated 43.2 million (95% UI: 37.5-48.2 million; 55% female) people were blind, 295.3 (95% UI 267.0-325.5) million had MSVI, 257.3 (95% UI 232.2-284.7) million h…

Burden of diseasemedicine.medical_specialtyeducation.field_of_studyVisual acuityBlindnessbusiness.industryPopulationGlobal visionmedicine.diseaseExpert groupNear visionEpidemiologyMedicinemedicine.symptombusinesseducationDemographySSRN Electronic Journal
researchProduct

An innovative lipid-lowering approach to enhance attainment of low-density lipoprotein cholesterol goals

2020

Aims To improve attainment of LDL-cholesterol (LDL-c) targets, an expert group proposed an algorithm for lipid-lowering therapy during hospitalization for acute coronary syndrome and during follow-up. We aimed to assess adherence to this algorithm, and evaluate its impact on LDL-c levels and on attainment of therapeutic LDL-c targets in a population of post-acute coronary syndrome patients. Methods and results Prospective, observational study including patients admitted for acute coronary syndrome between February 2017 and September 2018. Patients admitted without statins or ezetimibe were considered ‘naïve’. Baseline LDL-c was admission LDL-c in naïve patients, and for those taking lipid-…

Malemedicine.medical_specialtyAcute coronary syndromeStatinmedicine.drug_classLow density lipoprotein cholesterol030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineLipid-lowering therapy03 medical and health sciences0302 clinical medicineEzetimibeInternal medicinemedicineHumansProspective Studies030212 general & internal medicineAcute Coronary SyndromeAgedbusiness.industryAnticholesteremic AgentsCholesterol LDLGeneral MedicineEzetimibePrognosismedicine.diseaseExpert groupHospitalizationCardiologyPatient ComplianceLDL Cholesterol LipoproteinsFemalelipids (amino acids peptides and proteins)Lipid loweringCardiology and Cardiovascular MedicinebusinessAlgorithmsBiomarkersFollow-Up Studiesmedicine.drugEuropean Heart Journal. Acute Cardiovascular Care
researchProduct

Treatment sequence of synchronously (liver) metastasized colon cancer

2016

No standards for staging, systemic therapy or the timing of an operation are defined for patients newly diagnosed with synchronous metastases and a primary in the colon. An expert group of radiologists, medical, radiation and surgical oncologists therefore came together to discuss staging and treatment sequence for these patients and came up with a recommendation based on current evidence of potential therapeutic options. The discussion was organized to debate recommendations centred on 5 topics and therefore the position paper is built upon these titles and their subtitles. Editrice Gastroenterologica Italiana S.r.l.

Oncologymedicine.medical_specialtyColonColorectal cancermedicine.medical_treatment030230 surgeryTreatment sequenceSystemic therapy03 medical and health sciencesLiver metastases0302 clinical medicinePharmacotherapyDrug TherapyInternal medicinemedicineHepatectomyHumansCombined Modality TherapyTreatment optionsNeoplasm StagingHepatologybusiness.industryGeneral surgeryLiver NeoplasmsGastroenterologyAntineoplastic Protocolsmedicine.diseaseCombined Modality TherapyExpert groupColorectal cancerLiver030220 oncology & carcinogenesisPosition paperHepatectomyColorectal NeoplasmsbusinessSynchronous presentation
researchProduct

Towards human exploration of space: the THESEUS review series on cardiovascular, respiratory, and renal research priorities

2016

International audience; The THESEUS project (Towards Human Exploration of Space: aEUropean Strategy) was initiated within the seventh FrameworkProgramme by the European Commission. This project aimed toprovide a cross-cutting, life science-based roadmap for Europe’sstrategy towards human exploration of space, especially for deepspace missions and its relevance to applications on Earth. Toaddress these challenges, relevance of space research on thecardiovascular system, the lungs and kidneys, was discussed in anexpert group and its principal conclusions will be presented in thisarticle.

[SDE] Environmental SciencesEngineeringPhysics and Astronomy (miscellaneous)MathematicsofComputing_GENERALMedicine (miscellaneous)astronauts[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tractSpace exploration[ SDE ] Environmental SciencesDeep space missionsInformationSystems_GENERAL0302 clinical medicineblood-pressure[ SHS.INFO ] Humanities and Social Sciences/Library and information sciencesEuropean commissionSpace researchComputingMilieux_MISCELLANEOUSexercise[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO][ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemAgricultural and Biological Sciences (miscellaneous)Expert groupcentral venous-pressureEditorial[SDE]Environmental SciencesEngineering ethics[ SDV.MHEP.HEG ] Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyMaterials Science (miscellaneous)[SHS.INFO]Humanities and Social Sciences/Library and information sciencesBiochemistry Genetics and Molecular Biology (miscellaneous)GeneralLiterature_MISCELLANEOUS03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]long-duration spaceflightRelevance (information retrieval)heart-rateSimulationbusiness.industryPrincipal (computer security)[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology030229 sport sciencesmicrogravity13. Climate actionSpace and Planetary Sciencestationfoot forcesorthostatic intolerancebusiness030217 neurology & neurosurgery[ SDV.MHEP.PSR ] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract
researchProduct

Institutional logics and social enterprises: Entry mode choices of foreign hospitals in China

2020

When social enterprises, being defined by their social mission and profitability, internationalize, they need to\ud respond to institutional logics in the host country. By juxtaposing institutional logic and entry mode choice\ud literature, this paper shows how social enterprises accommodate different institutional logics when they enter\ud foreign markets. We collected data on Chinese healthcare reform, governmental policies and their changes, and\ud conducted 36 in-depth interviews and three expert group meetings. By analyzing five non-Chinese hospitals\ud entering China, we show how social enterprises, as hybrid organizations, respond to governmental, commercial,\ud and social institutio…

institutional logichybrid organizationMarketingChinabusiness.industryentry mode05 social sciencesSocial missionMode (statistics)social enterpriseExpert groupInstitutional logicMarket economy0502 economics and businessHealth care050211 marketingProfitability indexBusinessBusiness and International ManagementMode choiceChinaforeign hospital050203 business & managementFinanceJournal of World Business
researchProduct

Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diab…

2017

Aims These recommendations aim to improve care for patients with type 2 diabetes (T2D) at high cardiovascular (CV) risk in Central and Eastern Europe. Cardiovascular disease (CVD) and/or chronic kidney disease (CKD) are major interdependent comorbidities in patients with T2D, accounting for 50% of mortality. Following recent CV outcomes trial (CVOT) results, including those from EMPA-REG OUTCOME®, LEADER®, SUSTAIN™-6 and, most recently, the CANVAS study, it is essential to develop regional expert consensus recommendations to aid physicians in interpreting these newest data to clinical practice. Methods The Central and Eastern European Diabetes Expert Group (CEEDEG) followed a Delphi method …

lcsh:Diseases of the circulatory (Cardiovascular) systemKeywords: Anti-glycaemic drugs ; Cardiovascular disease ; Renal disease ; Type 2 diabetesmedicine.medical_specialtyEndocrinology Diabetes and Metabolism10265 Clinic for Endocrinology and DiabetologyDelphi method610 Medicine & health030209 endocrinology & metabolismReviewType 2 diabetesDisease030204 cardiovascular system & hematologyAnti-glycaemic drugs2705 Cardiology and Cardiovascular MedicineTranslational Research BiomedicalRenal disease03 medical and health sciences0302 clinical medicineMultidisciplinary approachDiabetes mellitusDiabetes MellitusmedicineHumansHypoglycemic AgentsEurope EasternIntensive care medicineExpert TestimonyClinical Trials as Topicbusiness.industryType 2 diabetesCardiovascular diseasemedicine.diseaseExpert groupEuropeEastern european2712 Endocrinology Diabetes and MetabolismTreatment Outcome2724 Internal MedicineCardiovascular Diseaseslcsh:RC666-701Practice Guidelines as TopicCardiology and Cardiovascular MedicinebusinessKidney diseaseCardiovascular Diabetology
researchProduct

Development of a Parkinson’s disease specific falls questionnaire

2020

Abstract Background Falls are a major health burden for older adults with Parkinson’s disease (PD), but there is currently no reliable questionnaire to capture the circumstances and consequences of falls in older adults with PD. This study aimed to develop a PD-specific falls questionnaire and to evaluate its test-retest reliability in older adults with PD. Methods A novel PD-specific falls questionnaire (PDF-Q) was developed in two modes (online and paper-based version) and used to assess falls and near-falls events over the past 12-months. Questions were agreed upon by an expert group, with the domains based on previous falls-related questionnaires. The questions included the number and c…

medicine.medical_specialtykyselytutkimusFalls in older adultsParkinsonin tautinear-fallsSurveys and QuestionnairesNear-fallsfallsMedicineHumansAgedreliabiliteettikaatuminenreliabilityMedical treatmentGeriatrics gerontologybusiness.industryQuestionnaireResearchquestionnaireRC952-954.6Reproducibility of ResultsParkinson DiseaseReliabilityExpert groupGeriatricsPhysical therapyParkinson’s diseaseFallsGeriatrics and GerontologybusinessikääntyneetBMC Geriatrics
researchProduct